Remzi Anadol

Randomised, non-inferiority, controlled procedural outcomes TrIal comParing reverse T And Protrusion versus double-kissing and crush stenting: protocol of the TIP TAP I randomised trial.

Journal: BMJ open

Published: June 20, 2020

Effectiveness of additional X-ray protection devices in reducing scattered radiation in radial intervention: the ESPRESSO randomised trial.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Published: April 28, 2020

Five Years Outcomes and Predictors of Events in a Single-Center Cohort of Patients Treated with Bioresorbable Coronary Vascular Scaffolds.

Journal: Journal of clinical medicine

Published: January 02, 2020

QFR Predicts the Incidence of Long-Term Adverse Events in Patients with Suspected CAD: Feasibility and Reproducibility of the Method.

Journal: Journal of clinical medicine

Published: December 26, 2019

Effectiveness of additional X-ray protection devices in reducing Scattered radiation in radial interventions: protocol of the ESPRESSO randomised trial.

Journal: BMJ open

Published: July 06, 2019

Incidental Finding of Strut Malapposition Is a Predictor of Late and Very Late Thrombosis in Coronary Bioresorbable Scaffolds.

Journal: Journal of clinical medicine

Published: March 19, 2019

Procedural Predictors for Bioresorbable Vascular Scaffold Thrombosis: Analysis of the Individual Components of the "PSP" Technique.

Journal: Journal of clinical medicine

Published: December 06, 2018

Tako-Tsubo syndrome, spontaneous coronary dissection and microvascular disease: Sex-differences.

Journal: Clinical hemorheology and microcirculation

Published: October 16, 2018

Bioresorbable everolimus-eluting vascular scaffold for patients presenting with non STelevation-acute coronary syndrome: A three-years follow-up1.

Journal: Clinical hemorheology and microcirculation

Published: April 10, 2018

Bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: a meta-analysis.

Journal: BMC cardiovascular disorders

Published: March 19, 2018

Three-years outcomes of diabetic patients treated with coronary bioresorbable scaffolds.

Journal: BMC cardiovascular disorders

Published: January 14, 2018

Predictors of bioresorbable scaffold failure in STEMI patients at 3 years follow-up.

Journal: International journal of cardiology

Published: November 16, 2017

Randomised, non-inferiority, controlled procedural outcomes TrIal comParing reverse T And Protrusion versus double-kissing and crush stenting: protocol of the TIP TAP I randomised trial.

Randomised, non-inferiority, controlled procedural outcomes TrIal comParing reverse T And Protrusion versus double-kissing and crush stenting: protocol of the TIP TAP I randomised trial.

Effectiveness of additional X-ray protection devices in reducing scattered radiation in radial intervention: the ESPRESSO randomised trial.

Effectiveness of additional X-ray protection devices in reducing scattered radiation in radial intervention: the ESPRESSO randomised trial.

Five Years Outcomes and Predictors of Events in a Single-Center Cohort of Patients Treated with Bioresorbable Coronary Vascular Scaffolds.

Five Years Outcomes and Predictors of Events in a Single-Center Cohort of Patients Treated with Bioresorbable Coronary Vascular Scaffolds.

QFR Predicts the Incidence of Long-Term Adverse Events in Patients with Suspected CAD: Feasibility and Reproducibility of the Method.

QFR Predicts the Incidence of Long-Term Adverse Events in Patients with Suspected CAD: Feasibility and Reproducibility of the Method.

Effectiveness of additional X-ray protection devices in reducing Scattered radiation in radial interventions: protocol of the ESPRESSO randomised trial.

Effectiveness of additional X-ray protection devices in reducing Scattered radiation in radial interventions: protocol of the ESPRESSO randomised trial.

Incidental Finding of Strut Malapposition Is a Predictor of Late and Very Late Thrombosis in Coronary Bioresorbable Scaffolds.

Incidental Finding of Strut Malapposition Is a Predictor of Late and Very Late Thrombosis in Coronary Bioresorbable Scaffolds.

Procedural Predictors for Bioresorbable Vascular Scaffold Thrombosis: Analysis of the Individual Components of the "PSP" Technique.

Procedural Predictors for Bioresorbable Vascular Scaffold Thrombosis: Analysis of the Individual Components of the "PSP" Technique.

Tako-Tsubo syndrome, spontaneous coronary dissection and microvascular disease: Sex-differences.

Tako-Tsubo syndrome, spontaneous coronary dissection and microvascular disease: Sex-differences.

Bioresorbable everolimus-eluting vascular scaffold for patients presenting with non STelevation-acute coronary syndrome: A three-years follow-up1.

Bioresorbable everolimus-eluting vascular scaffold for patients presenting with non STelevation-acute coronary syndrome: A three-years follow-up1.

Bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: a meta-analysis.

Bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: a meta-analysis.

Three-years outcomes of diabetic patients treated with coronary bioresorbable scaffolds.

Three-years outcomes of diabetic patients treated with coronary bioresorbable scaffolds.

Predictors of bioresorbable scaffold failure in STEMI patients at 3 years follow-up.

Predictors of bioresorbable scaffold failure in STEMI patients at 3 years follow-up.

Predictors of bioresorbable scaffold failure in STEMI patients at 3 years follow-up.

Predictors of bioresorbable scaffold failure in STEMI patients at 3 years follow-up.